Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Monotherapy in Refractory Partial Onset Seizures
NCT00266591Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 1992
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in focal onset seizure, sponsored by Johnson & Johnson. Started Oct 1992; status: completed.
02
Drugs
topiramate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00266591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266591.